RNLX vs. CUTR, ENCP, QMCO, IZEA, ICAD, LINK, PXDT, SYPR, MNDO, and DZSI
Should you be buying Renalytix stock or one of its competitors? The main competitors of Renalytix include Cutera (CUTR), Energem (ENCP), Quantum (QMCO), IZEA Worldwide (IZEA), iCAD (ICAD), Interlink Electronics (LINK), Pixie Dust Technologies (PXDT), Sypris Solutions (SYPR), MIND C.T.I. (MNDO), and DZS (DZSI). These companies are all part of the "computer and technology" sector.
Renalytix (NASDAQ:RNLX) and Cutera (NASDAQ:CUTR) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, profitability, institutional ownership, dividends, analyst recommendations, valuation and community ranking.
Cutera received 326 more outperform votes than Renalytix when rated by MarketBeat users. Likewise, 64.98% of users gave Cutera an outperform vote while only 32.00% of users gave Renalytix an outperform vote.
9.9% of Renalytix shares are held by institutional investors. Comparatively, 90.7% of Cutera shares are held by institutional investors. 18.3% of Renalytix shares are held by insiders. Comparatively, 2.1% of Cutera shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Cutera has a net margin of -68.87% compared to Renalytix's net margin of -1,736.47%. Cutera's return on equity of 0.00% beat Renalytix's return on equity.
Renalytix presently has a consensus target price of $5.00, suggesting a potential upside of 730.70%. Cutera has a consensus target price of $14.75, suggesting a potential upside of 599.05%. Given Renalytix's stronger consensus rating and higher probable upside, analysts clearly believe Renalytix is more favorable than Cutera.
In the previous week, Renalytix and Renalytix both had 1 articles in the media. Renalytix's average media sentiment score of 1.00 beat Cutera's score of 0.00 indicating that Renalytix is being referred to more favorably in the media.
Renalytix has a beta of 3.03, indicating that its share price is 203% more volatile than the S&P 500. Comparatively, Cutera has a beta of 1.66, indicating that its share price is 66% more volatile than the S&P 500.
Renalytix has higher earnings, but lower revenue than Cutera. Renalytix is trading at a lower price-to-earnings ratio than Cutera, indicating that it is currently the more affordable of the two stocks.
Summary
Cutera beats Renalytix on 9 of the 17 factors compared between the two stocks.
Get Renalytix News Delivered to You Automatically
Sign up to receive the latest news and ratings for RNLX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RNLX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Renalytix Competitors List
Related Companies and Tools
